Federal Trade Commission staff said a bill that would regulate pharmacy benefit managers in North Dakota would be anticompetitive with the unintended consequences of increasing drug prices and ultimately decreasing the number of state residents with prescription drug coverage. The North Dakota House passed the bill 85 to 3, and it awaits a vote in the Senate. State Sen. Richard Brown, who sought the FTC analysis, said he believed the Senate would amend the bill to address competitive concerns. The bill would regulate PBM contracts with health plans and pharmacies, prohibiting certain drug substitutions and requiring PBMs to charge the same copayment and deductible under all health plans. -- by Mark Taylor
N.D. plan to regulate PBMs deemed anticompetitive
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.